🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Acute kidney injury, an underrecognized feature of VEXAS syndrome Kambiz Kalantari, MD, MS Loren Herrera MD Lynn D. Cornell, M.D. fernando fervenza #MayoClinicKidney academic.oup.com/rheumatology/a…

Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient? fernando fervenza Shane Bobart, MD, FASN ASN Publications journals.lww.com/cjasn/citation…

Check out our editorial in ASN Publications #CJASN on an excellent study by Laurence H Beck, Jr and team. fernando fervenza Mayo Clinic Nephrology

Mayo MGRS Prediction Tool calculator mdevans.shinyapps.io/mgrs_app/

Membranous nephropathy treatment standard 🧐What are the novel developments in the pathophysiology of MN including the identification of target antigens and current treatment standards for MN? 👇👇👇 doi.org/10.1093/ndt/gf…

My mentor and colleague Mayo Clinic Dr. Ayalew Tefferi will be honored with the Giants of Cancer Care Award OncLive.com tomorrow. #ASCO25 Dr. Tefferi and I work together as Editors of Blood Cancer Journal He is one of the most influential and amazing educators in medicine.

🌍 The 7th International Renal Meeting with Mayo Clinic in Sardinia 🇮🇹 Powerful keynote by Dr. Ulrich Specks “PLEX in AAVGN: Time to let go of the old” MayoPCCM sardiniameeting.it/event/the-seve… Andrea Angioi, MD, FASN fernando fervenza

Our Mayo Clinic Nephrology ‘s Dr. Fernando C. Fervenza presented: “Lupus Nephritis: Redefining Treatment Goals” fernando fervenza Followed by thought-provoking discussions on lupus nephritis- Dr. Ayoub and Dr.Fervenza The 7th International Renal Meeting in Sardinia 🇮🇹 Andrea Angioi, MD, FASN

1. Is this MGRS? This is common when we see CKD patients with monoclonal gammopathy? Our work in KI can aid clinician in this situation! Let's dive in this paper! kidney-international.org/article/S0085-… Ladan Zand fernando fervenza Sanjeev Sethi Mayo Clinic Nephrology UMN Division of Nephrology & Hypertension American Society of Onconephrology

Very excellent talk by Dr. Sandra Herrmann Sandra Herrmann MD, FASN “Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-Nephrology” 🌍 The 7th International Renal Meeting with Mayo Clinic in Sardinia 🇮🇹 2025 Mayo Clinic Nephrology

Wisit Cheungpasitporn MD FACP | FASN | FAST Mayo Clinic Nephrology Thanks Dr Pani and Dr Roccatello for having us . Wisit Cheungpasitporn MD FACP | FASN | FAST

🧠 A highly informative and outstanding talk by Dr. Andrea Angioi Andrea Angioi, MD, FASN (Cagliari, Italy) on “MGRS: Classification and Clinical Presentation” 🌍 The 7th International Renal Meeting with Mayo Clinic in Sardinia 🇮🇹 📍Sa Manifattura, Cagliari | June 1, 2025 #onconeph

💬 A truly engaging and insightful panel discussion on Monoclonal Gammopathy of Renal Significance (MGRS): Classification and Treatment featuring: 🔹 Dr. Andrea Angioi (Cagliari, Italy) Andrea Angioi, MD, FASN 🔹 Dr. Daniele Derudas (Cagliari, Italy) #onconeph #nephrology

🌍 Honored to give a big shout-out to the amazing nephrology team @ Cagliari, Italy 🇮🇹 wonderful educators and friends 👏 Dr. Andrea Angioi Andrea Angioi, MD, FASN , Dr. Nicola Lepori Nicola Lepori , Dr. Matteo Floris Matteo , Dr. Doloretta Piras , amd Prof. Antonello Pani— thank

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy Ladan Zand Nattawat Klomjit maria jose vargas Sanjeev Sethi fernando fervenza kidney-international.org/article/S0085-…

Long-term Outcome of Adult Patients with Membranous Nephropathy treated with Rituximab fernando fervenza maria jose vargas Ilario Russo, MD Sanjeev Sethi Ladan Zand kireports.org/article/S2468-…

Outstanding Debate ERA - European Renal Association “Kidney biopsy versus biomarkers and new diagnostic tools in immune check point inhibitors AKI” by María José Soler (Spain) Maria Jose Soler Sandra Herrmann (USA) Sandra Herrmann MD, FASN Special thank Clara García Carro Jolanta Malyszko YNP of ERA Onconefrologia

Clinicopathological Characteristics and Long-Term Kidney Outcomes in Biopsy-Proven Renal Sarcoidosis Jing ^_^ Wisit Cheungpasitporn MD FACP | FASN | FAST Ladan Zand fernando fervenza ASN Publications journals.lww.com/kidney360/abst…

In this paper we describe group of patients with MN who had negative IF for PLA2R but had PLA2R detected by LM/MS! Kidney International ⁦Sanjeev Sethi⁩ ⁦Ilario Russo, MD⁩ ⁦fernando fervenza⁩ kidney-international.org/article/S0085-…

PLA2R-associated MN by LM/MS in patients with negative IF for PLA2R! Such an honor for me to work with you on this! Sanjeev Sethi Ladan Zand maria jose vargas fernando fervenza